Inventor · disambiguated record
Deborah M. Smith
Also filed as: SMITH DEBORAH · SMITH DEBORAH M · SMITH DEBORAH MARGARET
6 granted patents·5 pending applications·30 citations·filing 2008–2019
77Inventor score
Technology areasA61P
Files withEDWARDS JAMES P5GLAXOSMITHKLINE LLC3Janseen Pharmaceutiacal NV1LOVE CHRISTOPHER JOHN1SMITHKLINE BEECHAM CORP1
Top patents by PatentIndex Score
11 records- 0185US8431704B2Quinoline or isoquinoline substituted P2X7 antagonistsLOVE CHRISTOPHER JOHN·Filed 2009·Granted Apr 30, 2013·24 cites·12 claims
- 0284US8193178B2Thieno- and furo-pyrimidine modulators of the histamine H4 receptorEDWARDS JAMES P·Filed 2008·Granted Jun 5, 2012·6 cites·8 claims
- 0357US8937075B2Thieno- and furo-pyrimidine modulators of the histamine H4 receptorEDWARDS JAMES P·Filed 2012·Granted Jan 20, 2015·0 cites·9 claims
- 0457US8927555B2Thieno- and furo-pyrimidine modulators of the histamine H4 receptorEDWARDS JAMES P·Filed 2012·Granted Jan 6, 2015·0 cites·8 claims
- 0557US8445482B2Thieno- and furo-pyrimidine modulators of the histamine H4 receptorEDWARDS JAMES P·Filed 2012·Granted May 21, 2013·0 cites·8 claims
- 0657US8440654B2Thieno- and furo-pyrimidine modulators of the histamine H4 receptorEDWARDS JAMES P·Filed 2012·Granted May 14, 2013·0 cites·7 claims
- 0756US2020040073A1Methods for administering anti-il-5 antibodiesGLAXOSMITHKLINE LLC·Filed 2019·Application pending·0 cites
- 0855US2011218338A12-aminopyrimidine modulators of the histamine h4 receptorJanseen Pharmaceutiacal NV·Filed 2011·Application pending·0 cites
- 0954US2010086547A1Methods for administering anti-il-5 antibodiesSMITHKLINE BEECHAM CORP·Filed 2008·Application pending·0 cites
- 1051US2018022799A1Methods for administering anti-il-5 antibodiesGLAXOSMITHKLINE LLC·Filed 2017·Application pending·0 cites
- 1145US2016096886A1Methods for administering anti-il-5 antibodiesGLAXOSMITHKLINE LLC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Deborah M. Smith files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →